VHCP Co-Investment Holdings III, LLC — SEC Form 4 filings
SEC reporting owner CIK 1750761. 14 Form 4 filings on record with FilingPulse; latest filed 2026-03-27.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-01-10 to 2026-03-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 32 legs across 12 filings — 1,156,725 shares, $13,656,248 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 5 legs across 1 filing — 214,631 shares, $3,691,148 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: sale of 174,485 shares @ $16.95 ($2,957,521) in KalVista Pharmaceuticals, Inc., filed 2026-03-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) | 10% owner | 13 | 27 legs · 1,033,843 sh · $12,248,880 | 5 legs · 214,631 sh · $3,691,148 | 1 |
| Oruka Therapeutics, Inc. (ORKA) | 10% owner | 1 | 5 legs · 122,882 sh · $1,407,368 | — | — |
Form 4 filings — VHCP Co-Investment Holdings III, LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-27 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, Koh Bong Y, Shah Nimish P | Sale (S): 174,485 @ $16.95 · Sale (S): 160 @ $17.53 · Sale (S): 21,386 @ $17.76 · Sale (S): 15,417 @ $18.82 · Sale (S): 3,183 @ $19.12 | EDGAR |
| 2025-04-11 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, Koh Bong Y, Shah Nimish P | Purchase (P): 25,000 @ $9.42 | EDGAR |
| 2025-02-27 | 4 | Oruka Therapeutics, Inc. (ORKA) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, Koh Bong Y, Shah Nimish P | Purchase (P): 574 @ $10.90 · Purchase (P): 9,593 @ $10.95 · Purchase (P): 8,971 @ $11.86 · Purchase (P): 14,950 @ $11.63 · Purchase (P): 88,794 @ $11.44 | EDGAR |
| 2025-02-14 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, Koh Bong Y, Shah Nimish P | Purchase (P): 100,000 @ $9.23 · Purchase (P): 61,700 @ $9.33 | EDGAR |
| 2025-02-11 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, Koh Bong Y, Shah Nimish P | Purchase (P): 73,649 @ $9.29 · Purchase (P): 4,137 @ $9.14 · Purchase (P): 26,703 @ $9.18 | EDGAR |
| 2025-02-03 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, Koh Bong Y, Shah Nimish P | Purchase (P): 43,707 @ $8.76 · Purchase (P): 11,754 @ $8.89 · Purchase (P): 14,562 @ $9.22 | EDGAR |
| 2024-02-22 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., Koh Bong Y, VHCP Management III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., Shah Nimish P | Purchase (P): 655,738 (derivative) @ $15.25 | EDGAR |
| 2024-02-08 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., Koh Bong Y, VHCP Management III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., Shah Nimish P | Purchase (P): 4,474 @ $14.74 · Purchase (P): 51,827 @ $14.56 · Purchase (P): 29,747 @ $14.70 | EDGAR |
| 2024-02-01 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., Koh Bong Y, VHCP Management III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., Shah Nimish P | Purchase (P): 88,099 @ $14.47 | EDGAR |
| 2024-01-29 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., Koh Bong Y, VHCP Management III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., Shah Nimish P | Purchase (P): 7,030 @ $12.73 · Purchase (P): 4,174 @ $12.98 · Purchase (P): 80,600 @ $14.22 | EDGAR |
| 2024-01-24 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., Koh Bong Y, VHCP Management III, LLC, VHCP Management EG, LLC, Venrock Healthcare Capital Partners EG, L.P., Shah Nimish P | Purchase (P): 67,546 @ $12.55 · Purchase (P): 10,897 @ $12.54 · Purchase (P): 20,686 @ $12.44 | EDGAR |
| 2024-01-19 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y, Shah Nimish P | Purchase (P): 78,925 @ $12.60 · Purchase (P): 39,680 @ $12.51 · Purchase (P): 25,000 @ $12.43 | EDGAR |
| 2024-01-16 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y, Shah Nimish P | Purchase (P): 6,647 @ $12.68 · Purchase (P): 19,599 @ $12.73 | EDGAR |
| 2024-01-10 | 4 | KalVista Pharmaceuticals, Inc. (KALV) jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, Koh Bong Y, Shah Nimish P | Purchase (P): 69,184 @ $12.44 · Purchase (P): 20,816 @ $12.56 · Purchase (P): 47,700 @ $12.67 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1750761 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →